BBVA USA’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$13K Sell
902
-184
-17% -$3.11K ﹤0.01% 809
2021
Q2
$20K Buy
+1,086
New +$19.3K ﹤0.01% 803

Other funds holding SBRA

BBVA USA's SBRA Position: Q3 2021 in Review

BBVA USA reduced its Sabra Healthcare REIT (SBRA) stake by 17% in Q3 2021, selling an estimated $3.11K and leaving 902 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #809.

BBVA USA first reported a position in SBRA in Q2 2021 and has held it in 2 quarters since. The position peaked at $20K in Q2 2021. 326 funds tracked by Wall St. Rank hold SBRA as of Q3 2021.

  • BBVA USA held 902 shares of Sabra Healthcare REIT worth $13K as of Q3 2021.
  • BBVA USA sold 184 Sabra Healthcare REIT shares in Q3 2021, an estimated $3.11K.
  • Sabra Healthcare REIT made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #809 holding.
  • BBVA USA first reported a position in Sabra Healthcare REIT in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's Sabra Healthcare REIT position peaked at $20K in Q2 2021.
  • 326 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.